Status:
COMPLETED
Safety Evaluation of Sericin-chitosan Cream in Healthy Volunteers
Lead Sponsor:
Chulalongkorn University
Conditions:
Pressure Sore
Safety Issues
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
A prospective, randomized, active-controlled clinical trial was conducted to evaluate safety of sericin-chitosan cream in healthy volunteers.
Detailed Description
A prospective, randomized, active-controlled clinical trial was conducted to initially evaluate safety of sericin-chitosan cream in comparison with a commercially available cream containing dimethicon...
Eligibility Criteria
Inclusion
- Healthy volunteers at the age of 20 - 65 years
- voluntarily sign inform consent
Exclusion
- Diagnosed with chronic skin conditions (e g. eczema and psoriasis) and immunocompromised diseases
- Allergic to silk sericin and chitosan, and dimethicone
- Received immunosuppressive therapy, antihistamine, and corticosteroid drugs two weeks before study enrollment.
Key Trial Info
Start Date :
February 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 25 2020
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT04729556
Start Date
February 15 2020
End Date
June 25 2020
Last Update
January 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn Unviersity
Bangkok, Thailand, 10310